CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 

Oct 28, 2024 - 03:05 PM
A clinicians gloved hand draws a syringe of vaccine from a vial.


The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to receive a second dose of the 2024-2025 COVID-19 vaccine. The recommendation from the Advisory Committee on Immunization Practices, which calls for the second dose to be administered six months after the first dose, acknowledges the increased risk of severe disease from COVID-19 for older adults and immunocompromised individuals, along with the latest data on vaccine effectiveness and year-round circulation of COVID-19. It also provides clarity to health care providers on how many doses should be given per year to people who are moderately or severely immunocompromised and is intended to increase coverage of a second dose for that group. 

Additionally, the agency recommended lowering the age for initial pneumococcal vaccination from 65 to 50, as the risk for infection substantially increases at that age. 

Related News Articles

Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…